Elevated Circulating Pigment Epithelium-Derived Factor Predicts the Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes

被引:51
|
作者
Hui, Elaine [1 ,2 ]
Yeung, Chun-Yip [1 ]
Lee, Paul C. H. [1 ]
Woo, Yu-Cho [1 ]
Fong, Carol H. Y. [1 ]
Chow, Wing-Sun [1 ]
Xu, Aimin [1 ,2 ,3 ]
Lam, Karen S. L. [1 ,2 ,3 ]
机构
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Res Ctr Heart Brain Hormones & Hlth Aging, Pokfulam, Hong Kong, Peoples R China
[3] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Pokfulam, Hong Kong, Peoples R China
来源
关键词
FACTOR PEDF; INSULIN-RESISTANCE; PLASMA-CONCENTRATION; METABOLIC SYNDROME; KIDNEY-FUNCTION; DISEASE; MARKER; LEVEL; ADIPOCYTES; CREATININE;
D O I
10.1210/jc.2014-2235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Pigment epithelium-derived factor (PEDF), a circulating glycoprotein with antiangiogenic, antioxidative, and anti-inflammatory properties, protects against diabetic nephropathy (DN) in animal models. Objective: We investigated whether circulating PEDF predicted the progression of DN in a 4-year prospective study. Design, Setting, and Participants: Baseline plasma PEDF levels were measured in type 2 diabetic subjects recruited from the Hong Kong West Diabetes Registry. The role of PEDF in predicting chronic kidney disease (CKD) and albuminuria progression was analyzed using Cox regression analysis. Main Outcome Measure: We evaluated CKD progression, defined as deterioration in CKD staging and a 25% or greater drop in estimated glomerular filtration rate (eGFR) according to International Society of Nephrology statements. Results: At baseline, plasma PEDF levels increased progressively with CKD staging (P for trend <.001; n = 1136). Among 1071 subjects with baseline CKD stage <= 3, plasma PEDF levels were significantly higher in those with CKD progression(n = 171) during follow-up than those without(P < .001). Baseline PEDF was independently associated with CKD progression (hazard ratio = 2.76; 95% confidence interval = 1.39-5.47; P = .004), adjusted for age, sex, waist circumference, diabetes duration, hemoglobin A1c, systolic blood pressure, use of antihypertensive drugs, C-reactive protein, and eGFR. Elevated baseline PEDF was also associated with the development of microalbuminuria/albuminuria in a subgroup with normoalbuminuria and eGFR > 60 mL/min/1.73 m(2) (n = 462) at baseline (hazard ratio = 2.75; 95% confidence interval = 1.01-7.49; P < .05), even after adjustment for potential confounders. Conclusions: Elevated PEDF levels may represent a compensatory change in type 2 diabetic patients with renal disease and appear to be a useful marker for evaluating the progression of DN.
引用
收藏
页码:E2169 / E2177
页数:9
相关论文
共 50 条
  • [11] Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy
    Wang, Joshua J.
    Zhang, Sarah X.
    Mott, Robert
    Chen, Ying
    Knapp, Ryan R.
    Cao, Wei
    Ma, Jian-xing
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 294 (05) : F1166 - F1173
  • [12] The effects of calcium channel blockers on nephropathy and pigment epithelium-derived factor in the treatment of hypertensive patients with type 2 diabetes mellitus
    Tabur, Suzan
    Oguz, Elif
    Sabuncu, Tevfik
    Korkmaz, Hakan
    Celik, Hakim
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2015, 37 (03) : 177 - 183
  • [13] Pigment epithelium-derived factor, an endogenous inhibitor of transforming growth factor β, is implicated in diabetic nephropathy
    Ma, JX
    Wang, JJ
    Zhang, SX
    Lu, K
    Chen, Y
    Mott, R
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S272 - S272
  • [14] Salutary effect of pigment epithelium-derived factor in diabetic nephropathy - Evidence for antifibrogenic activities
    Wang, Joshua J.
    Zhang, Sarah X.
    Mott, Robert
    Knapp, Ryan R.
    Cao, Wei
    Lau, Kai
    Ma, Jian-xing
    DIABETES, 2006, 55 (06) : 1678 - 1685
  • [15] Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy
    Ogata, Nahoko
    Matsuoka, Masato
    Matsuyama, Kayako
    Shima, Chieko
    Tajika, Aran
    Nishiyama, Toshiyuki
    Wada, Mitsumasa
    Jo, Nobuo
    Higuchi, Akiko
    Minamino, Keizo
    Matsunaga, Hiroshi
    Takeda, Toshihiko
    Matsumura, Miyo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (03): : 1176 - 1179
  • [16] Elevated plasma concentrations of pigment epithelium-derived factor in type 2 diabetic patients is reduced by metformin treatment in association with weight loss
    Ge, Zhijuan
    Zhang, Pengzi
    Bi, Yan
    Li, Cuiliu
    Yang, Huijie
    Zhu, Dalong
    JOURNAL OF DIABETES, 2015, 7 (05) : 740 - 742
  • [17] Pigment epithelium-derived factor increases in type 2 diabetes after treatment with metformin
    Akin, Safak
    Aksoy, Duygu Yazgan
    Cinar, Nese
    Aydin, Kadriye
    Karaagaoglu, Ergun
    Ariyurek, Macit
    Gulcelik, Nese Ersoz
    Usman, Aydan
    Gurlek, Alper
    CLINICAL ENDOCRINOLOGY, 2012, 77 (06) : 852 - 856
  • [18] Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis
    Kuncl, RW
    Bilak, MM
    Bilak, SR
    Corse, AM
    Royal, W
    Becerra, SP
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 (01) : 178 - 184
  • [19] Increased Serum Pigment Epithelium-Derived Factor in Women with Gestational Diabetes Is Associated with Type 2 Diabetes
    Li, Tong-Huan
    Qiu, Chun-Jian
    Yu, Xiao-Juan
    Liu, Dan-Dan
    Zhou, Peng-Fei
    Wu, Liang
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [20] Lack of Circulating Pigment Epithelium-Derived Factor Is a Marker of Osteogenesis Imperfecta Type VI
    Rauch, Frank
    Husseini, Abdallah
    Roughley, Peter
    Glorieux, Francis H.
    Moffatt, Pierre
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (08): : E1550 - E1556